Amdocs Limited Reports Record Quarterly Revenue of $841M, Up 4.0% YoY

Expects FY2013 Non-GAAP EPS Growth Towards the Higher-End of the Previous Expectation of 5-8%

31 Jul, 2013, 16:03 ET from Amdocs

ST. LOUIS, July 31, 2013 /PRNewswire/ --

Key highlights:

  • Third fiscal quarter revenue of $841 million, within the $825-$855 million guidance range. Foreign currency movements negatively affected revenue by approximately $4 million relative to the second quarter of fiscal 2013
  • Third fiscal quarter non-GAAP operating income of $142 million; non-GAAP operating margin of 16.8%; GAAP operating income of $123 million
  • Third fiscal quarter diluted non-GAAP EPS of $0.83, compared to the $0.70-$0.76 guidance range, excluding amortization of purchased intangible assets and other acquisition related costs and equity-based compensation expense, net of related tax effects. A lower non-GAAP effective tax rate positively impacted diluted non-GAAP EPS by approximately $0.10
  • Diluted GAAP EPS of $0.73 for the third fiscal quarter, compared to the $0.60-$0.68 guidance range. A lower GAAP effective tax rate positively impacted diluted GAAP EPS by approximately $0.10
  • Free cash flow of $151 million for the third fiscal quarter
  • Twelve-month backlog of $2.83 billion at the end of the third fiscal quarter, up $20 million from the end of the second quarter of fiscal 2013
  • Repurchased $58 million of ordinary shares during the third fiscal quarter
  • The board of directors approved a $0.13 per share quarterly cash dividend to be paid on October 18, 2013
  • Fourth quarter fiscal 2013 guidance: Expected revenue of approximately $830-$860 million and diluted non-GAAP EPS of $0.60-$0.66, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.04-$0.05 per share of equity-based compensation expense, net of related tax effects. Diluted non-GAAP EPS guidance includes an expected negative impact of approximately $0.10 due to a higher non-GAAP effective tax rate in the fourth fiscal quarter. The non-GAAP effective tax rate for the full fiscal year 2013 is still anticipated to be within the previously expected range of 13%-15%. Diluted GAAP EPS is expected to be approximately $0.50-$0.58. Diluted GAAP EPS guidance includes an expected negative impact of approximately $0.10 due to a higher GAAP effective tax rate in the fourth fiscal quarter.

Amdocs Limited (NYSE: DOX) today reported that for its fiscal quarter ended June 30, 2013, revenue was $841.3 million, up 1.0% sequentially from the second fiscal quarter of 2013 and up 4.0% as compared to last year's third fiscal quarter. Net income on a non-GAAP basis was $134.4 million, or $0.83 per diluted share, compared to non-GAAP net income of $118.4 million, or $0.70 per diluted share, in the third quarter of fiscal 2012. Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition related costs and equity-based compensation expenses of $14.9 million, net of related tax effects, in the third quarter of fiscal 2013 and excludes such amortization and other acquisition related costs and equity-based compensation expenses of $19.6 million, net of related tax effects, in the third quarter of fiscal 2012. The Company's GAAP net income for the third quarter of fiscal 2013 was $119.6 million, or $0.73 per diluted share, compared to GAAP net income of $98.8 million, or $0.59 per diluted share, in the prior fiscal year's third quarter. 

"We are pleased with our solid performance in the third fiscal quarter. Despite currency headwinds, we delivered revenue growth of 4% year-over-year, driven by continued strength in North America. AT&T was an important contributor to our performance, and we are also seeing growth at other key customers in North America. In the emerging markets, we remain focused on bringing many highly complex transformation projects into production, and we continue to see a substantial pipeline of opportunity with new and existing customers. Finally, in Europe, while overall economic conditions in the region remain challenging, we delivered another quarter of relatively consistent revenue on a sequential basis" said Eli Gelman, chief executive officer of Amdocs Management Limited.

Gelman continued, "We continued to sign strategic customer wins during the third fiscal quarter.  In North America, Amdocs was selected by Aio Wireless, a new, no-annual-contract wireless service, to provide managed services across Amdocs' business support systems (BSS), web portal and mobile applications, as well as to manage third party applications.  In Europe, we signed a five-year managed services agreement with a major European wireless group to manage its customer care and billing systems in a newly established shared services and development center.  In replacing a number of vendors with Amdocs, we believe this agreement is evidence of the value Amdocs can bring with managed services in Europe as operators seek to simplify and improve the quality of their operations. The contracts with Aio and the European operator demonstrate Amdocs' ability to deliver value, and, as such, grow our business in existing customers through the breadth of our product family and our expanded services capabilities that extend beyond Amdocs' own systems."

Gelman concluded, "As we embark on the fourth fiscal quarter, we will continue to monitor macroeconomic and industry conditions closely. These include the near term uncertainty arising from the effects of consolidation amongst North American carriers, challenging conditions in Europe, and some slowdown in subscriber and economic growth in segments of the emerging markets, all of which can affect the pace and scope of business demand. We remain keenly focused on our growth initiatives, our operational execution and capital efficiency.  As a result, we now expect to deliver non-GAAP EPS growth towards the higher end of our prior expectation of 5-8%."

Financial Discussion of Third Fiscal Quarter Results Free cash flow was $151 million for the quarter, comprised of cash flow from operations of $173 million less $22 million in net capital expenditures and other.

Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $2.83 billion at the end of the third quarter of fiscal 2013. 

Financial Outlook Amdocs expects that revenue for the fourth quarter of fiscal 2013 will be approximately $830-$860 million. Diluted earnings per share on a non-GAAP basis for the fourth fiscal quarter are expected to be $0.60-$0.66, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.04-$0.05 per share of equity-based compensation expense, net of related tax effects. Amdocs estimates GAAP diluted earnings per share for the fourth fiscal quarter will be $0.50-$0.58

Quarterly Cash Dividend Program On July 31, 2013, the Board approved the Company's next quarterly cash dividend payment and set September 30, 2013 as the record date for determining the shareholders entitled to receive the dividend, which is payable on October 18, 2013.

Conference Call Details Amdocs will host a conference call on July 31, 2013 at 5:00 p.m. Eastern Time to discuss the Company's third fiscal quarter results. The call will be carried live on the Internet via the Amdocs website, www.amdocs.com.

Non-GAAP Financial Measures This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expense, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP earnings per share growth. These non-GAAP measures exclude the following items:

  • amortization of purchased intangible assets and other acquisition related costs;
  • gain on sale of investment;
  • equity-based compensation expense; and
  • tax effects related to the above.

These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs' results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs' results of operations in conjunction with the corresponding GAAP measures.

Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expense, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

For its internal budgeting process and in monitoring the results of the business, Amdocs' management uses financial statements that do not include amortization of purchased intangible assets and other acquisition related costs, gain on sale of investment, equity-based compensation expense and related tax effects. Amdocs' management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.

Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of service, research and development, selling, general and administrative, operating income, interest and other expense, net, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.

About Amdocs For 30 years, Amdocs has ensured service providers' success and embraced their biggest challenges. To win in the connected world, service providers rely on Amdocs to simplify the customer experience, harness the data explosion, stay ahead with new services and improve operational efficiency. The global company uniquely combines a market-leading BSS, OSS and network control product portfolio with value-driven professional services and managed services operations.  With revenue of $3.2 billion in fiscal 2012, Amdocs and its approximately 20,000 employees serve customers in more than 60 countries.

Amdocs: Embrace Challenge, Experience Success.

For more information, visit Amdocs at www.amdocs.com.

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs' growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs' ability to grow in the business markets that it serves, Amdocs' ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, the Company specifically disclaims any obligation to do so. These and other risks are discussed at greater length in the Company's filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2012 filed on December 11, 2012, our Form 6-K furnished for the first quarter of fiscal 2013 on February 12, 2013 and our Form 6-K furnished for the second quarter of fiscal 2013 on May 16, 2013.

 

AMDOCS LIMITED

Consolidated Statements of Income (in thousands, except per share data)

Three months ended

Nine months ended

June 30,

June 30,

2013

2012

2013

2012

Revenue:

License

$           18,616

$           34,443

$         59,433

$        96,477

Service

822,716

774,394

2,441,196

2,328,298

841,332

808,837

2,500,629

2,424,775

Operating expenses:

Cost of license

561

1,056

1,839

2,982

Cost of service

546,108

519,217

1,619,215

1,552,947

Research and development

59,583

58,858

179,002

180,515

Selling, general and administrative

103,396

106,678

313,539

319,857

Amortization of purchased intangible      assets and other

8,520

12,977

28,358

39,503

718,168

698,786

2,141,953

2,095,804

Operating income

123,164

110,051

358,676

328,971

Interest and other expense, net

2,726

2,737

4,591

1,064

Income before income taxes

120,438

107,314

354,085

327,907

Income taxes

880

8,565

30,600

34,557

Net income

$         119,558

$           98,749

$      323,485

$       293,350

Basic earnings per share

$               0.74

$               0.59

$            2.00

$             1.73

Diluted earnings per share

$               0.73

$               0.59

$            1.98

$             1.72

Basic weighted average number of shares      outstanding

160,914

167,194

161,350

169,890

Diluted weighted average number of       shares outstanding

162,667

168,290

163,048

171,033

Cash dividends declared per share

$               0.13

$                     -

$            0.39

$                  -

 

AMDOCS LIMITED

Selected Financial Metrics

(in thousands, except per share data)

Three months ended

Nine months ended

June 30,

June 30,

2013

2012

2013

2012

Revenue

$    841,332

$      808,837

$    2,500,629

$    2,424,775

Non-GAAP operating income

141,551

134,338

418,935

401,457

Non-GAAP net income

134,430

118,357

373,154

344,314

Non-GAAP diluted earnings per      share

$           0.83

$            0.70

$             2.29

$             2.01

Diluted weighted average number      of shares outstanding

162,667

168,290

163,048

171,033

 

AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

 (in thousands)

Three months ended June 30, 2013

Reconciliation items

GAAP

Amortization of purchased intangible assets and other

Equity based compensation expense

Tax effect

Non-GAAP

Operating expenses:

Cost of license

$        561

$             -

$             -

$          -

$           561

Cost of service

546,108

-

(4,937)

-

541,171

Research and      development

59,583

-

(1,060)

-

58,523

Selling, general and       administrative

103,396

-

(3,870)

-

99,526

Amortization of      purchased intangible      assets and other

8,520

(8,520)

-

-

-

Total operating expenses

718,168

(8,520)

(9,867)

-

699,781

Operating income

123,164

8,520

9,867

-

141,551

Income taxes

880

-

-

3,515

4,395

Net income

$ 119,558

$      8,520

$      9,867

$ (3,515)

$    134,430

Three months ended

June 30, 2012

Reconciliation items

GAAP

Amortization of purchased intangible assets and other

Equity based compensation expense

Tax effect

Non-GAAP

Operating expenses:

Cost of license

$      1,056

$              -

$              -

$           -

$        1,056

Cost of service

519,217

-

(6,010)

-

513,207

Research and      development

58,858

-

(1,068)

-

57,790

Selling, general and      administrative

106,678

-

(4,232)

-

102,446

Amortization of      purchased intangible      assets and other

12,977

(12,977)

-

-

-

Total operating expenses

698,786

(12,977)

(11,310)

-

674,499

Operating income

110,051

12,977

11,310

-

134,338

Income taxes

8,565

-

-

4,679

13,244

Net income

$    98,749

$    12,977

$     11,310

$ (4,679)

$    118,357

 

AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(in thousands)

Nine months ended June 30, 2013

Reconciliation items

GAAP

Amortization of purchased intangible assets and other

Equity based compensation expense

Tax effect

Non-GAAP

Operating expenses:

Cost of license

$     1,839

$                 -

$                 -

$            -

$      1,839

Cost of service

1,619,215

-

(14,440)

-

1,604,775

Research and      development

179,002

-

 

(3,060)

-

175,942

Selling, general and       administrative

313,539

-

 

(14,401)

-

299,138

Amortization of      purchased intangible      assets and other

28,358

(28,358)

-

-

-

Total operating expenses

2,141,953

(28,358)

(31,901)

-

2,081,694

Operating income

358,676

28,358

31,901

-

418,935

Income taxes

30,600

-

-

10,590

41,190

Net income

$ 323,485

$       28,358

$       31,901

$ (10,590)

$  373,154

Nine months ended June 30, 2012

Reconciliation items

GAAP

Amortization of purchased intangible assets and other

Equity based compensation expense

Gain on sale of investment

Tax effect

 

Non-GAAP

Operating expenses:

Cost of license

$      2,982

$                 -

$                 -

$                 -

$             -

$     2,982

Cost of service

1,552,947

-

(17,376)

-

-

1,535,571

Research and      development

180,515

-

 

(3,281)

-

-

177,234

Selling, general and      administrative

319,857

-

 

(12,326)

-

-

307,531

Amortization of      purchased intangible      assets and other

39,503

(39,503)

-

-

-

-

Total operating expenses

2,095,804

(39,503)

(32,983)

-

-

2,023,318

Operating income

328,971

39,503

32,983

-

-

401,457

Interest and other      expense, net

 

1,064

-

-

 

6,270

-

 

7,334

Income taxes

34,557

-

-

-

15,252

49,809

Net income

$  293,350

$       39,503

$       32,983

$        (6,270)

$  (15,252)

$ 344,314

 

AMDOCS LIMITED

Condensed Consolidated Balance Sheets

 (in thousands)

As of

June 30, 2013

September 30, 2012

ASSETS

Current assets

Cash, cash equivalents and short-term interest-bearing investments

$      1,090,699

$      1,118,177

Accounts receivable, net, including unbilled of $124,197 and $130,697,      respectively

667,748

687,223

Deferred income taxes and taxes receivable

124,395

109,282

Prepaid expenses and other current assets

162,737

126,388

    Total current assets

2,045,579

2,041,070

Equipment and leasehold improvements, net

261,933

277,907

Goodwill and other intangible assets, net

1,854,435

1,883,064

Other noncurrent assets

398,872

443,182

Total assets

$      4,560,819

$      4,645,223

LIABILITIES AND SHAREHOLDERS' EQUITY

Current Liabilities

Accounts payable, accruals and other

$         602,699

$         690,823

Short-term financing arrangements

-

200,000

Deferred revenue

133,060

145,184

Deferred income taxes and taxes payable

38,058

29,551

    Total current liabilities

773,817

1,065,558

Other noncurrent liabilities

547,205

546,463

Shareholders' equity

3,239,797

3,033,202

Total liabilities and shareholders' equity

$      4,560,819

$      4,645,223

 

AMDOCS LIMITED

Consolidated Statements of Cash Flows

(in thousands)

Nine months ended June 30,

2013

2012

Cash Flow from Operating Activities:

Net income

$             323,485

$             293,350

Reconciliation of net income to net cash provided by operating activities:

    Depreciation and amortization

107,400

119,261

    Equity-based compensation expense

31,901

32,983

    Deferred income taxes

1,829

(13,587)

Excess tax benefit from equity-based compensation

(275)

(140)

Gain on sale of investment

-

(9,172)

    Loss from short-term interest-bearing investments

1,873

2,403

Net changes in operating assets and liabilities:

    Accounts receivable

31,559

(101,302)

    Prepaid expenses and other current assets

(12,010)

(11,222)

    Other noncurrent assets

23,056

21,559

    Accounts payable, accrued expenses and accrued personnel

(59,279)

41,501

    Deferred revenue

(18,360)

(19,415)

    Income taxes payable

(14,391)

11,053

    Other noncurrent liabilities

22,054

(5,259)

Net cash provided by operating activities

438,842

362,013

Cash Flow from Investing Activities:

Payments for purchase of equipment and leasehold improvements, net

(80,151)

(79,223)

Proceeds from sale of short-term interest-bearing investments

258,121

288,334

Purchase of short-term interest-bearing investments

(324,982)

(257,958)

Cash received from sale of investment

-

11,172

Other

(4,161)

(6,237)

Net cash used in investing activities

(151,173)

(43,912)

Cash Flow from Financing Activities:

Payments under financing arrangements

(200,000)

(250,000)

Repurchase of shares

(270,251)

(378,404)

Proceeds from employee stock options exercised

154,105

63,085

Payments of dividends

(63,079)

-

Payments under capital lease and other

(825)

(383)

Net cash used in financing activities

(380,050)

(565,702)

Net decrease in cash and cash equivalents

(92,381)

(247,601)

Cash and cash equivalents at beginning of period

879,158

831,371

Cash and cash equivalents at end of period

$             786,777

$             583,770

 

AMDOCS LIMITED

Supplementary Information

 (in millions)

Three months ended

June 30, 2013

March 31, 2013

December 31, 2012

September 30, 2012

June 30, 2012

North America

$      619.2

$      601.3

$      593.6

$      570.4

$      558.7

Europe

98.0

99.3

99.2

113.1

106.5

Rest of World

124.1

132.3

133.6

138.6

143.6

Total Revenue

$      841.3

$      832.9

$      826.4

$      822.1

$      808.8

Three months ended

June 30,

2013

March 31, 2013

December 31, 2012

September 30, 2012

June 30, 2012

Emerging Markets Revenue

$      101.3

$        98.1

$        98.2

$        99.9

$      101.7

Three months ended

June 30, 2013

March 31, 2013

December 31, 2012

September 30, 2012

June 30, 2012

Managed Services Revenue

$      417.1

$      439.8

$      429.8

$      423.7

$      426.8

Three months ended

June 30, 2013

March 31, 2013

December 31, 2012

September 30, 2012

June 30, 2012

Customer Experience Systems

$      803.2

$      789.3

$      783.8

$      783.1

$      766.2

Directory

38.1

43.6

42.6

39.0

42.6

Total Revenue

$      841.3

$      832.9

$      826.4

$      822.1

$      808.8

As of

June 30, 2013

March 31, 2013

December 31, 2012

September 30, 2012

June 30, 2012

12-Month Backlog

$      2,830

$      2,810

$      2,800

$      2,790

$      2,760

 

 

 

SOURCE Amdocs



RELATED LINKS

http://www.amdocs.com